Study Summary Reports 5-MeO-DMT Reduces Symptoms of Treatment-Resistant Depression

A study summarized by Examine.com indicates that inhaling 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), a short-acting psychedelic tryptamine, led to a reduction in symptoms of treatment-resistant depression and even remission. While the findings suggest a positive effect, the summary notes that the psychedelic effects and high rates of adverse events (such as nausea) likely informed participants of their treatment, potentially influencing the reported antidepressant effects. This research represents a significant finding in the field of mental health and potential new treatment avenues.